New Law Aims to Expose Big Pharma Influence on Physicians
It is no secret that the medical field is heavily influenced by the pharmaceutical industry. For many decades, health care professionals and pharmaceutical companies have enjoyed cozy financial relationships. Pharmaceuticals continuously interact with medical doctors (MDs) and Doctors of Osteopathy (DOs), the two types of physicians who are licensed for prescribe…
U.S. Senate Passes Bill Approving Mandatory Vaccinations for Veterans
Fundamentally, biological warfare is sneaky. It involves a microbial sucker punch to its intended target, often accomplished in a manner in which the aggressor can claim clean hands, while his victim may suffer or die. Biological warfare can take a number of forms. The question—how can you get a bacteriological or toxic agent on board without the target being alerted…
The 21st Century Cures Act On Its Way Through Congress
The 21st Century Cures Act is going through the U.S. Congress right now, and it will likely pass into law unless some opposition materializes (it passed through the House of Representatives with a vote 344 to 77 on July 10, 2015). The Act is a give-away to the pharmaceutical industry, removing many of the safety mechanisms in place that are supposed to keep the…
The 21st Century Cures Act: Say Goodbye to Vaccine Safety Science
It has only been a few weeks since the forced vaccination lobby rammed a bill (SB 277) through the California legislature eliminating the personal belief vaccine exemption so children will have to get dozens of doses of federally recommended vaccines or be denied a school education.1 While California was being subjected to one of the […]
NVIC: 21st Century Cures Act Will Lower FDA Drug Licensing Standards
The non-profit National Vaccine Information Center (NVIC) says the proposed 21st Century Cures Act (H.R. 6) will endanger the public health by lowering scientific and informed consent standards used by the Food and Drug Administration (FDA) to license experimental biological products (vaccines), drugs and medical devices in order to expedite delivery to the U.S. market.
